Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Angela Jack
The risks of corporate ‘washing’ - the D&O laundry list
Angela Jack | Executive Head | Specialty, Broking & Risk Solutions | Aon South Africa | mail me | In today’s competitive marketplace, companies face mounting pressure to attract and retain investors. This pressure can tempt leaders to overstate achievements or inflate projections. Some may also resort to window dressing. While these tactics can polish a company’s image, they raise the risks of corporate ‘washing’. More seriously, they can cross into misrepresentation or securities fraud.
A Shift in School Reform: Examining Site-Level Spending and Student Academic Growth
Introduction The demand for improved student academic performance in the United States has led to a wave of education reform efforts. The enactment of the Every Student Succeeds Act of 2015 (ESSA) continues the nation’s commitment to providing all public school children with fair and equitable educational opportunities.
Court of Appeal dismisses Tesco’s appeal in trade mark dispute with Lidl
The Court of Appeal has recently handed down its decision in an appeal by Tesco against findings of trade mark infringement, passing off and copyright infringement in their use of signs to advertise Clubcard prices, CCP Signs, and a cross appeal by Lidl against a finding of invalidity of the Wordless Mark. Wordless Mark Example CCP Sign The only one of those findings overturned by the Court of Appeal was the finding of copyright infringement. The leading judgment is given by Arnold LJ.
A closer look at the trademark dispute between retail giants Lidl and Tesco
Angela Jack dissects the recent ruling in Lidl Great Britain Ltd & others v Tesco Stores Limited & others [2023] EWHC 873 (Ch) Mrs Justice Joanna Smith DBE has recently issued a judgment in the dispute between Lidl and Tesco, which concerned Lidl’s trademarks and related rights.
COVID-19: D&O claims could go viral as a result of the pandemic
Angela Jack | Business Unit Head | Financial Services Group | Aon South Africa | mail me | On March 12, 2020, a plaintiff shareholder filed a securities class action lawsuit against Norwegian Cruise Line Holdings, alleging that the company was employing misleading sales tactics related to COVID-19 bookings and cancellations¹. Another D&O claim was lodged soon after against Inovio Pharmaceuticals relating to statements the company made about developing a vaccine for COVID-19².
Could D&O claims go viral following actions taken during COVID-19 pandemic?
Reading Time: 4 minutes Unprecedented challenges requiring immediate decisions could have significant future ramifications By Angela Jack, Business Unit Head: Financial Services Group at Aon South Africa On March 12, 2020, a plaintiff shareholder filed a securities class action lawsuit against Norwegian Cruise Line Holdings, alleging that the company was employing misleading sales tactics related to COVID-19 bookings and cancellations¹.
Could D&O claims go viral following actions taken during COVID-19 pandemic?
Unprecedented challenges requiring immediate decisions could have significant future ramifications By Angela Jack, Business Unit Head: Financial Services Group at Aon South Africa On March 12, 2020, a plaintiff shareholder filed a securities class action lawsuit against Norwegian Cruise Line Holdings, alleging that the company was employing misleading sales tactics related to COVID-19 bookings and cancellations¹.
More pain for Pfizer-second medical use claims not infringed
More pain for Pfizer—second medical use claims not infringed Generics (UK) Ltd (t/a Mylan) v Warner-Lambert Company Ltd, [2015] EWHC 2548 (Pat) Abstract A patent for a second medical use of a known drug was not infringed where it was not foreseeable to a generic manufacturer that a doctor prescribing, or a pharmacist dispensing, a potentially infringing product intended that some of the generic manufacturer’s product would be used for the patented second use. © The Author(s) (2016.
More pain for Pfizer-second medical use claims not infringed
More pain for Pfizer—second medical use claims not infringed Generics (UK) Ltd (t/a Mylan) v Warner-Lambert Company Ltd, [2015] EWHC 2548 (Pat) Abstract A patent for a second medical use of a known drug was not infringed where it was not foreseeable to a generic manufacturer that a doctor prescribing, or a pharmacist dispensing, a potentially infringing product intended that some of the generic manufacturer’s product would be used for the patented second use. © The Author(s) (2016.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Angela
Contact Angela, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack